Methylphenidate Efficacy: Immediate versus Extended Release at Short Term in Mexican Children with ADHD Assessed by Conners Scale and EEG

Abstract

Attention deficit hyperactivity disorder (ADHD) affects 5-6% of school aged children worldwide. Pharmacological therapy is considered the first-line treatment and methylphenidate (MPH) is considered the first-choice medication. There are two formulations: immediate release (IR) MPH and long-acting (or extended release) formulation (MPH-ER). In this work, we measure the efficacy of treatment for both presentations in one month with Conners' scales and electroencephalography (EEG). Results. for IR group, in parents and teachers Conners test, all items showed significant differences, towards improvement, except for teachers in perfectionism and emotional instability. For ER group in parent's Conners test, the items in which there were no significant differences are psychosomatic and emotional instability. For teachers, there were no significant differences in: hyperactivity and perfectionism. Comparing the Conners questionnaires (parents versus teachers) we find significant differences before and after treatment in hyperactivity, perfectionism, psychosomatics, DSM-IV hyperactive-impulsive, and DSM-IV total. In the EEG the Wilcoxon test showed a significant difference (P < 0.0001). As we can see, both presentations are suitable for managing the ADHD and have the same effect on the symptomatology and in the EEG.

The association between methylphenidate treatment and the risk for fracture among young ADHD patients: A nationwide population-based study in Taiwan

“…In Taiwan, methylphenidate was the only stimulant approved for ADHD treatment during 1996 to 2013, including short- and sustained-release preparations The two preparations of methylphenidate had similar effects on ADHD symptoms, but the sustained-release preparation was more convenient with lesser rebound side effects [ 30 , 31 ]. Atomoxetine, a non-stimulant, was also approved as a medication for ADHD in Taiwan since 2007.…”

Increased oxidative stress in children with attention deficit hyperactivity disorder

“…Home life may also be very difficult, as the constant activity of children with ADHD tends to cause conflict in their families. [5][6][7] The first-line treatment for patients with severe ADHD is considered pharmacological therapy, such as methylphenidate. 8 Curative therapy is not recommended for this disorder because the precise cause is not known.…”

Population Pharmacokinetics of Methylphenidate in Healthy Adults Emphasizing Novel and Known Effects of Several Carboxylesterase 1 (CES1) Variants

“…Methylphenidate (MPH), a central nervous system stimulant, is the most commonly prescribed drug for the treatment of patients with attention deficit hyperactive disorder . It is also prescribed for other conditions, such as narcolepsy in adults as well as depression in the elderly and patients with advanced illness .…”